Since it can cause people to lose almost 30 percent of their body weight, it will most likely be reserved for patients with severe obesity, currently defined as those with a body mass index (BMI) of over 40
The improvements were statistically significant and appeared independent of the degree of weight loss
At AgeRejuvenation, we offer this treatment as part of our peptide-based sexual wellness program built around how desire and arousal actually work, for patients dealing with changes in arousal, responsiveness, and sexual function
Quick Answer: GLP-1 receptor agonists are not licensed or supported by clinical evidence for rheumatoid arthritis treatment in the UK, and microdosing remains experimental without established safety or efficacy data
Supporting Science: Sleep, stress, digestion, hormones, and mindset all impact your weight (and quality of life)